Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | GPR183 | P32249 | 1/20 | 0.48 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6518475 | 0.87 | CYP2C19 (0.67) | CYP2D6ALDH1A1CYP2C19KMT2A | |
| SCHEMBL6519705 | 0.86 | CYP2D6 (0.71) | CYP2D6ALDH1A1CYP2C19KMT2A | |
| SCHEMBL3930198 | 0.85 | PKM (0.58) | CYP2D6ALDH1A1CYP2C19KMT2A | |
| SCHEMBL16013324 | 0.83 | HSD11B1 (0.62) | CYP2D6ALDH1A1GPR183GLA | |
| SCHEMBL6975890 | 0.81 | NEK2 (0.52) | ALDH1A1GPR183 | |
| SCHEMBL18065510 | 0.80 | ALDH1A1 (0.48) | ALDH1A1GPR183GLA | |
| SCHEMBL17393808 | 0.79 | HSD11B1 (0.53) | ALDH1A1GPR183GLA | |
| SCHEMBL9344505 | 0.77 | ALDH1A1 (0.65) | ALDH1A1GPR183GLA | |
| SCHEMBL31315858 | 0.77 | ALDH1A1 (0.65) | ALDH1A1GPR183GLA | |
| SCHEMBL16015073 | 0.76 | GLA (0.51) | ALDH1A1GPR183GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0925286-B1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ASTRAZENECA AB (SE) | 2003-01-02 | — | — | EP | disclosed |
| US-6093718-A | AN OXIDO-SQUALENE CYCLASE INHIBITOR, ANTICHOLESTEROL AGENT FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND LOWERING CHOLESTEROL LEVELS IN BLOOD PLASMA; TREATING HYPERCHOLESTEROLEMIA AND ATHEROSCLEROSIS | ZENECA LIMITED (GB) | 2000-07-25 | — | — | US | disclosed |
| EP-0925286-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ZENECA LIMITED (GB) | 1999-06-30 | — | — | EP | disclosed |
| WO-1998006705-A1 | SUBSTITUTED PYRIMIDINE DERIVATIVES AND THEIR PHARMACEUTICAL USE | ZENECA LIMITED (GB) | 1998-02-19 | — | — | WO | disclosed |